These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 390766)

  • 21. Mutagenicity of acrylonitrile and its metabolite 2-cyanoethylene oxide in human lymphoblasts in vitro.
    Recio L; Skopek TR
    Mutat Res; 1988 Oct; 206(2):297-305. PubMed ID: 3173396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic activation of dimethylnitrosamine and diethyl-nitrosamine to mutagens.
    Malling HV; Frantz CN
    Mutat Res; 1974 Nov; 25(2):179-86. PubMed ID: 4279332
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatotoxic effects of acrylonitrile in rats [proceedings].
    Noël G; Lambotte-Vandepaer M; Duverger-van Bogaert M; Roberfroid M; Mercier M
    Arch Int Physiol Biochim; 1978 Oct; 86(4):951-2. PubMed ID: 84641
    [No Abstract]   [Full Text] [Related]  

  • 24. Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains.
    Bartsch H; Malaveille C; Montesano R
    Int J Cancer; 1975 Mar; 15(3):429-37. PubMed ID: 1095499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro metabolic activation of chemical mutagens. I. Development of an in vitro mutagenicity assay using liver microsomal enzymes for the activation of dimethylnitrosamine to a mutagen.
    Gletten F; Weekes U; Brusick D
    Mutat Res; 1975 Apr; 28(1):113-22. PubMed ID: 806800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and mutagenicity of acrylonitrile: an in vivo study.
    Lambotte-Vandepaer M; Duverger-van Bogaert M; Rollmann B
    Environ Mutagen; 1985; 7(5):655-62. PubMed ID: 3899631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicity of N-nitrosodiethanolamine and its acetyl-derivatives [proceedings].
    Gilbert P; Rollmann B; Rondelet J; Mercier M; Poncelet F
    Arch Int Physiol Biochim; 1979 Oct; 87(4):813-4. PubMed ID: 93920
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic activation of emodin in the reconstituted cytochrome P-450 system of the hepatic microsomes of rats.
    Tanaka H; Morooka N; Haraikawa K; Ueno Y
    Mutat Res; 1987 Feb; 176(2):165-70. PubMed ID: 3100945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of microsomal enzymes in liver of rats treated with cyclohexanol.
    Espinosa-Aguirre JJ; Rubio J; Cassani M; Nosti R; Caballero S; González I; Martínez G
    Mutat Res; 1996 Jun; 368(2):103-7. PubMed ID: 8684399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mutagenicity of butadiene towards Salmonella typhimurium.
    de Meester C; Poncelet F; Roberfroid M; Mercier M
    Toxicol Lett; 1980 Aug; 6(3):125-30. PubMed ID: 6996220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of acrylonitrile to 2-cyanoethylene oxide in F-344 rat liver microsomes, lung microsomes, and lung cells.
    Roberts AE; Lacy SA; Pilon D; Turner MJ; Rickert DE
    Drug Metab Dispos; 1989; 17(5):481-6. PubMed ID: 2573490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. omega-Hydroxyemodin, a major hepatic metabolite of emodin in various animals and its mutagenic activity.
    Murakami H; Kobayashi J; Masuda T; Morooka N; Ueno Y
    Mutat Res; 1987 Oct; 180(2):147-53. PubMed ID: 3309636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
    Søderlund EJ; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P-450 content and the ability of liver microsomes from patients undergoing abdominal surgery to alter the mutagenicity of a primary and secondary carcinogen.
    Czygan P; Greim H; Garro AJ; Hutterer F; Rudick J; Schaffner F; Popper H
    J Natl Cancer Inst; 1973 Dec; 51(6):1761-4. PubMed ID: 4587754
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of acrylonitrile with the liver mixed function oxidases.
    Cova D; Chiesara E; Rizzi R
    Arch Toxicol Suppl; 1984; 7():291-4. PubMed ID: 6595995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity of acrylonitrile in mouse.
    Leonard A; Garny V; Poncelet F; Mercier M
    Toxicol Lett; 1981 Feb; 7(4-5):329-34. PubMed ID: 7222109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of acrylonitrile with hepatic microsomes of rats and men.
    Appel KE; Peter H; Bolt M; Bolt HM
    Toxicol Lett; 1981 Feb; 7(4-5):335-9. PubMed ID: 7222110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of metronidazole: activation by mammalian liver microsomes.
    Rosenkranz HS; Speck WT
    Biochem Biophys Res Commun; 1975 Sep; 66(2):520-5. PubMed ID: 1101888
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical effects of acrylonitrile on the rat liver, as influenced by various pretreatments of the animals.
    Duverger-van Bogaert M; Lambotte-Vandepaer M; Noël G; Roberfroid M; Mercier M
    Biochem Biophys Res Commun; 1978 Aug; 83(3):1117-24. PubMed ID: 213062
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of two urinary metabolites of rats treated with acrylonitrile; influence of several inhibitors on the mutagenicity of those urines.
    Lambotte-Vandepaer M; Duverger-Van Bogaert M; de Meester C; Rollmann B; Poncelet F; Mercier M
    Toxicol Lett; 1981 Feb; 7(4-5):321-7. PubMed ID: 7222108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.